GENPHARMASEC
Quarterly Results Analysis [Jun2025]
GENPHARMASEC Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹12 Cr | ₹14 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr |
Expenses | ₹11 Cr | ₹15 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr |
Operating Income | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit After Tax | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
EPS | ₹0.02 | ₹0.00 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.00 | ₹0.00 |
Industry Peers & Returns | 1W | 1M | 1Y |
GENPHARMASEC | -0.5% | -4% | -44.3% |
SUDARSHAN CHEMICAL INDUSTRIES | -3.6% | -1.7% | 41.5% |
KIRI INDUSTRIES | -1.4% | -7.7% | 33.8% |
VIDHI SPECIALTY FOOD INGREDIENTS | 1.7% | -2% | -13.2% |
SHREE PUSHKAR CHEMICALS & FERTILISERS | 10.6% | -8.7% | 36.8% |
BODAL CHEMICALS | 0.4% | -7% | -22.1% |
BHAGERIA INDUSTRIES | 0.3% | 11.2% | -14.8% |
DYNEMIC PRODUCTS | -0.6% | 2.9% | -14.1% |
PODDAR PIGMENTS | 2.8% | -9.4% | -38.7% |
GENPHARMASEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -14.04 % |
Y-o-Y | 131.82 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹12 Cr | -14.04 | |
Mar2025 | ₹14 Cr | 65.13 | |
Dec2024 | ₹8 Cr | 40.63 | |
Sep2024 | ₹6 Cr | 16.13 | |
Jun2024 | ₹5 Cr | -49.06 | |
Mar2024 | ₹10 Cr | 59.73 | |
Dec2023 | ₹6 Cr | -18.76 | |
Sep2023 | ₹8 Cr | - |
GENPHARMASEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 427.53 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹1 Cr | Positive | |
Mar2025 | ₹-1 Cr | Negative | |
Dec2024 | ₹1 Cr | 475.00 | |
Sep2024 | ₹0 Cr | -28.09 | |
Jun2024 | ₹0 Cr | Positive | |
Mar2024 | ₹0 Cr | Negative | |
Dec2023 | ₹0 Cr | Positive | |
Sep2023 | ₹0 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 127.41 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 7.8% | Positive | |
Mar2025 | -7.13% | Negative | |
Dec2024 | 8.68% | 309.43 | |
Sep2024 | 2.12% | -38.19 | |
Jun2024 | 3.43% | Positive | |
Mar2024 | -0.13% | Negative | |
Dec2023 | 0.27% | Positive | |
Sep2023 | -0.53% | - |
GENPHARMASEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 323.00 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹1 Cr | Positive | |
Mar2025 | ₹0 Cr | Negative | |
Dec2024 | ₹1 Cr | 10.80 | |
Sep2024 | ₹1 Cr | 145.30 | |
Jun2024 | ₹0 Cr | -41.31 | |
Mar2024 | ₹0 Cr | 676.19 | |
Dec2023 | ₹0 Cr | 950.00 | |
Sep2023 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 82.61 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 10.08 % | Positive | |
Mar2025 | -1.93 % | Negative | |
Dec2024 | 9.19 % | -21.25 | |
Sep2024 | 11.67 % | 111.41 | |
Jun2024 | 5.52 % | 15.24 | |
Mar2024 | 4.79 % | 383.84 | |
Dec2023 | 0.99 % | 1,137.50 | |
Sep2023 | 0.08 % | - |
GENPHARMASEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 0 |
Y-o-Y | 100.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹0.02 | 0 | |
Mar2025 | ₹0 | -100.00 | |
Dec2024 | ₹0.01 | 0.00 | |
Sep2024 | ₹0.01 | 0.00 | |
Jun2024 | ₹0.01 | 0.00 | |
Mar2024 | ₹0.01 | 0 | |
Dec2023 | ₹0 | 0 | |
Sep2023 | ₹0 | - |
You may also like the below Video Courses